Clinical trial
Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam…
NCT00368537 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00368537 |
|---|---|
| Title | Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections |
| Official title | A Multicenter, Randomized, Open-Label Comparison of the Safety And Efficacy of Tigecycline With That of Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Complicated Skin And Skin Structure Infections |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Skin Diseases, Bacterial |
| Intervention type | Drug |
| Interventions | Tigecycline, ampicillin-sulbactam |
| Enrollment | 550 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Aug 24, 2006 |
| Last update posted | Aug 9, 2012 |
| Countries | Canada, Hong Kong, Israel, Lebanon, Malaysia, Philippines, Singapore, South Africa, South Korea, Taiwan, Thailand, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: